Clik here to view.
Dozens sue Bayer over Essure permanent contraceptive implants
Over 30 women are suing Bayer (ETR:BAYN) over injuries related to its Essure permanent birth control device, claiming the device led to severe health problems including abdominal cramping, migraines...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for March 22, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Endeavour Vision shifts focus to medtech with new $275m fund
Healthcare investor Endeavour Vision said today it it will shift its focus to medtech after raising $275 million (€250 million) in committed capital for its Endeavour Medtech Growth LP fund. The firm...
View ArticleClik here to view.
Sanuwave Health brings in $1.5m for dermaPACE
Sanuwave Health (OTC:SNWV) said Monday it closed a $1.5 million round of equity financing to help support the FDA submission of Phase III clinical trial data to support the clearance of its dermaPACE...
View ArticleClik here to view.
How to win early investors: Tips for gauging startup resources
How do you get companies or investors to support your project in a startup world where “many are called, few are chosen?” Vector attended a panel last week on the subject, moderated by Ryan Dietz,...
View ArticleClik here to view.
M3 medical portal, backed by Sony, gets into medical devices with MedTecHeart...
M3 Inc., a Sony (TYO:6758)-backed Japanese web portal for physicians, is getting into the medical device game with an investment in MedTecHeart and its outside-the-body cardiac assist device. A joint...
View ArticleClik here to view.
Trial kicks off in 10-year-old Abbott stent case
A 10-year-old whistleblower lawsuit filed by a former Abbott (NYSE:ABT) sales rep, over the alleged off-label marketing of biliary stents, finally went to trial in Dallas yesterday. Plaintiff Kevin...
View ArticleClik here to view.
Stryker launches $5m SurgiCount liability plan for retained sponges
Stryker (NYSE:SYK) said today it is launching the SurgiCount Promise risk-sharing program, offering up to $5 million in product-liability costs to hospitals which use its SurgiCount safety-sponge...
View ArticleClik here to view.
Philips Respironics settles kickbacks case for $35m
The Respironics division at Philips (NYSE:PHG) agreed to pay $34.8 million to settle U.S. Justice Dept. claims that it paid kickbacks in the form of free call center services to induce suppliers into...
View ArticleClik here to view.
FDA warns Terumo over vascular sheath
The FDA last week sent a warning letter to Terumo Corp. (TYO:4543) over issues with the manufacturing and quality control of its Destination Guiding vascular sheaths. The agency warned the company over...
View ArticleClik here to view.
FDA clears Stimwave’s StimQ wireless chronic pain stimulator
Stimwave Technologies said today that it’s putting its StimQ peripheral nerve stimulator on the U.S. market after winning pre-market approval from the FDA earlier this month. The StimQ device is...
View ArticleClik here to view.
Australian ImpediMed raises $56m in private placement
Australian medtech developer ImpediMed said yesterday it closed a $56.6 million (AUD $75.1 million) private placement financing round. The company develops and distributes medical devices which use...
View ArticleClik here to view.
Henry Schein expands footprint in Japan with J. Morita stake
Henry Schein (NSDQ:HSIC) said it’s expanding its footprint in the Japanese dental market by buying a 50% stake in a subsidiary of J. Morita Corp. for an undisclosed amount. Melville, N.Y.-based Schein...
View ArticleClik here to view.
FDA OKs improved MarginProbe device from Dune Medical
Dune Medical Devices said today it won pre-market approval from the FDA for modifications to its MarginProbe breast cancer surgical device designed for real-time detection of cancer in breast...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for March 23, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
ACell wins 510(k) for modified MicroMatrix
ACell said today it won additional FDA 510(k) clearance for its MicroMatrix device allowing the use of the device in conjunction with Cytal wound matrix or Cytal burn matrix devices. The MicroMatrix is...
View ArticleClik here to view.
Intersect ENT wins expanded FDA approval for Propel Mini
Intersect ENT (NSDQ:XENT) said today it won FDA premarket approval for an expanded indication for its Propel mini steroid releasing sinus implant designed to treat patients undergoing frontal sinus...
View ArticleClik here to view.
Amniox Medical touts foot ulcer study data
Amniox Medical today released results from a retrospective study of its Neox wound allograft in treating chronic diabetic foot ulcers touting an 87% rate of healing in patients treated with the...
View ArticleClik here to view.
Xeltis wins FDA nod for bioresorbable pulmonary valve
Xeltis said yesterday that the FDA designated the bioresorbable replacement pulmonary valve it’s developing as a humanitarian use device, granted for device designed to treat rare diseases. The Swiss...
View ArticleClik here to view.
Capsugel said to explore sale, IPO
Capsugel‘s private equity owner is said to be exploring a sale or initial public offering for the Pfizer (NYSE:PFE) spinout. A deal could value Capsugel, which makes hard capsules and drug delivery...
View Article